Skip to main content

UBS Group AG

Position in INDP — Indaptus Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in INDP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,434
-$82,961 QoQ
Shares Held
478
-98.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 9 holders
Holding Since
Sep 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INDP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. INDP ranks #506 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INDP

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,434 478
2025-12-31 $84,395 29,002
2025-09-30 $1,440 502
2025-03-31 $46 87
2024-12-31 $2,124 2,523
2024-09-30 $647 522
2024-06-30 $1,467 692
2024-03-31 $4,336 1,936
2023-12-31 $6,510 3,699
2023-09-30 $377 137
2023-06-30 $1,222 640
2022-03-31 $13,175 3,294
2021-12-31 $28,112 4,932
2021-09-30 $1,033 132